Bethesda, Md. (October 27, 2008): The Parenteral Drug Association (PDA) has confirmed that Ian Morrison will speak during the Opening Plenary Session at the 2009 PDA Annual Meeting in Las Vegas, Nevada, April 20-24, 2009. Morrison will kick off the 2009 PDA Annual Meeting with a keynote presentation that explores his ideas on long-term forecasting for healthcare. His presentation will set the stage for conference sessions focused on using today’s tools and technologies to better tomorrow’s bio/pharmaceutical industry.
Morrison is an internationally known author, consultant and futurist specializing in long-term forecasting and planning with a particular emphasis on healthcare. He has written, lectured and consulted on a wide variety of healthcare topics for government, industry and nonprofit organizations. Morrison is the author of Healthcare in the New Millennium: Vision, Values and Leadership and a co-author of Looking Ahead at American Healthcare. He is a founding partner of Strategic Health Perspectives, an ongoing forecasting service for clients in the healthcare industry, and a Senior Fellow at the Institute for the Future (IFTF).
Morrison’s Opening Plenary Session presentation will set the stage for two-and-a-half days of conference sessions focused on The Impact of the Microchip - Application of Modern Technologies in the Development, Manufacture and Testing of Bio/pharmaceutical Products. These sessions will examine the systems and tools that can help you and your company maximize efficiency and productivity, while consistently delivering safe, pure and reliable drugs to patients.
Immediately following the conference, the PDA Training and Research Institute (PDA TRI) is offering courses to complement conference sessions.
The 2009 PDA Annual Meeting will be held in Las Vegas, Nevada, April 20-24, 2009, at the Red Rock Casino, Resort and Spa.
For more information, visit www.pda.org/annual2009.
Connecting People, Science and Regulation®
The Parenteral Drug Association (PDA) is a nonprofit international organization and a leading global provider of science, technology, and regulatory information and education for the pharmaceutical and biopharmaceutical community. PDA is committed to developing scientifically sound, practical technical information and resources to advance science and regulation through the expertise of its more than 10,000 members worldwide. More information about PDA is available at www.pda.org.